We continue to monitor the unfolding global impact of COVID-19, and as the world evolves, so do we. We are transforming this event to be fully digital: The 2020 ISPE Continuous Manufacturing Virtual Workshop.
You will still:
Explore two tracks on continuous manufacturing for large molecules – drug substance, and continuous manufacturing for small molecules – drug product, drug substance, and API
Identify the supply chain, safety, and quality assurance advantages provided by continuous manufacturing
Learn about the different approaches to continuous manufacturing regarding equipment, measurement tools, and control strategies
Analyze avenues for enhanced communication with regulators on innovative and emerging technologies
It's our priority to make this the best and most informative 2020 ISPE Continuous Manufacturing Virtual Workshop to date, and we remain excited to host you in June. We will update the event page in the coming weeks with additional information.
The topic of continuous manufacturing has drawn considerable interest across all modalities of pharmaceutical manufacturing. Thus far much of the progress has been seen in small molecule drug product manufacturing platforms where multiple products have...
When we first launched the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) in 2017, we benefited from an incredible enthusiasm and engagement from across the ecosystem. At the time, academic institutions were working to...